Universität zu Köln

Journal Article

Cheah, Chan Y., Broeckelmann, Paul J., Chihara, Dai ORCID: 0000-0002-1153-2294, Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec C., Augustson, Bradley, Vose, Julie, Bartlett, Nancy L., Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina, Oki, Yasuhiro and Fanale, Michelle A. (2016). Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Am. J. Hematol., 91 (9). S. 894 - 900. HOBOKEN: WILEY. ISSN 1096-8652

Cheah, Chan Yoon, Broeckelmann, Paul J., Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec Christoffer, Vose, Julie, Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Chihara, Dai, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina S., Oki, Yasuhiro and Fanale, Michelle A. (2015). Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen, Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham and Younes, Anas (2015). Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Huebner, Dirk, Fong, Abraham and Younes, Anas (2016). Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma. Blood, 128 (12). S. 1562 - 1567. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chen, Robert W., Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Sievers, Eric L. and Younes, Anas (2012). Long-Term Survival Analyses of an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L. and Younes, Anas (2015). Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood, 125 (8). S. 1236 - 1244. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Gopal, Ajay K., Chen, Robert, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Chi, Xuedong, Sievers, Eric L. and Younes, Anas (2015). Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood, 125 (8). S. 1236 - 1244. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Gopal, Ajay K., Pro, Barbara, Connors, Joseph M., Younes, Anas, Engert, Andreas, Shustov, Andrei R., Chi, Xuedong, Larsen, Emily K., Kennedy, Dana A. and Sievers, Eric L. (2016). Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting. Clin. Trials, 13 (5). S. 545 - 555. LONDON: SAGE PUBLICATIONS LTD. ISSN 1740-7753

Karuturi, Meghan S., Arai, Sally, Chen, Robert W., Gopal, Ajay K., Feng, Lei, Yuan, Ying, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Ramchandren, Radhakrishnan, Bartlet, Nancy L., Cheson, Bruce D., Forero-Torres, Andres, Moskowitz, Craig H., Connors, Joseph M., Fanale, Michelle A., de Vos, Sven, Engert, Andreas, Illidge, Tim, Borchmann, Peter, Morschhauser, Franck, Horning, Sandra J. and Younes, Anas (2012). Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene ORCID: 0000-0001-7265-7691, Moccia, Alden ORCID: 0000-0001-8816-5464, Salles, Gilles, McKee, Thomas ORCID: 0000-0002-2147-3136, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter ORCID: 0000-0003-2306-4974, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves and Flahault, Antoine (2020). Resources-Stratified Guidelines for Classical Hodgkin Lymphoma. Int. J. Environ. Res. Public Health, 17 (5). BASEL: MDPI. ISSN 1660-4601